Frontlight ResearchEarly access
Hypertrophic cardiomyopathy trials in France
5 of 9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Not yet taking people in FranceStudy of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy
- Where
- Paris
- Age
- 6 years and over
- People
- 26 worldwide
- Run by
- Lexeo Therapeutics
See details and how to joinNCT07721025 · EU 2025-524970-40-00 - Phase 2Taking peopleA randomized, double-blinded, placebo-controlled trial to evaluate the efficacy and safety of ninerafaxstat in patients with symptomatic non-obstructive hypertrophic cardiomyopathy
- Where
- Montpellier, Paris, Saint-Herblain
- Age
- 18 years and over
- People
- 130 worldwide
- Run by
- Imbria Pharmaceuticals Inc.
See details and how to join2024-515125-28-00 - Phase 2Taking peopleA Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
- Where
- Montpellier, Paris, Saint-Herblain
- Age
- 18 years and over
- People
- 165 worldwide
- Run by
- Imbria Pharmaceuticals, Inc.
See details and how to joinNCT07023614 - Phase 2/3Taking peopleOpen-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM
- Where
- Marseille, Montpellier, Paris, Paris Cedex 15, Pessac, Rennes, Saint-Herblain, Toulouse Cedex 9
- Age
- 18 years to 85 years
- People
- 900 worldwide
- Run by
- Cytokinetics
See details and how to joinNCT04848506 · EU 2023-508963-58-00 - Phase 3Taking peopleLA-HCM Study : Rivaroxaban for Antithrombotic Prevention in Hypertrophic Cardiomyopathy Patients With Abnormal Left Atrial Strain.
- Where
- Angers, Bordeaux, Brest, Caen, Dijon, Grenoble, Lille, Marseille, Nantes, Paris, Rennes, Rouen, Toulouse, Tours, Vandœuvre-lès-Nancy
- Age
- 40 years to 80 years
- People
- 532
- Run by
- Rennes University Hospital
See details and how to joinNCT07202897 · EU 2024-511084-28-00